Viveve Medical: Of This Current Report On Form 8k (including Exhibit 99.1), The Company Is Unable To Present A Plan To Regain Compliance With The Bid Price Rule And The Equity Rule To The Panel At The Hearing. Accordingly, Nasdaq Will Delist The Company By Filing A Form 25 Notification Of Delisting With The Securities And Exchange Commission. Following The Effectiveness Of The Delisting, The Company Intends To File A Form 15 With The Securities And Exchange Commission To Suspend Its Reporting Obligations Under The Securities Exchange Act Of 1934, As Amended

Show full article

This functionality is available for registred users only

• Full name
  Viveve Medical, Inc.
• Registration country
  USA
• Industry
  Medical Devices
• М/S&P/F
  *** / *** / ***